Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangju is a Traditional Chinese Medicine (TCM) formula, commonly available as Xiangju tablets (Xiangju Pian) or capsules, used for the treatment of inflammatory and allergic conditions of the upper respiratory tract. The formula typically includes botanical extracts such as *Chrysanthemum indicum*, *Angelica dahurica*, *Magnolia biondii*, and *Astragalus membranaceus*. It is primarily indicated for seasonal allergic rhinitis, chronic rhinitis, and sinusitis. Xiangju is thought to work by modulating the immune system, reducing the production of pro-inflammatory cytokines and immunoglobulin E (IgE), and exerting anti-allergic effects to alleviate symptoms like nasal congestion, sneezing, and rhinorrhea.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiangju.